Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
| NAV22/01/2025 | Diferencia+0.4300 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 199.6900CHF | +0.22% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | - | - | - | - | - | 3.81 | -8.64 | -3.97 | -2.99 | - |
| 2017 | 5.37 | 6.71 | -0.01 | 0.96 | -3.17 | 9.25 | 2.21 | 6.79 | 0.75 | -6.79 | -0.06 | 1.28 | +24.55% |
| 2018 | 6.46 | -4.80 | -2.39 | -3.41 | 4.34 | 0.58 | 4.21 | 3.87 | -2.28 | -14.26 | 3.88 | -8.61 | -13.65% |
| 2019 | 12.82 | 3.37 | -0.81 | -5.23 | -4.67 | 9.15 | -2.44 | -2.53 | -4.73 | 10.96 | 11.86 | 2.51 | +31.48% |
| 2020 | -5.43 | -1.60 | -5.43 | 12.23 | 9.44 | 1.20 | -3.00 | 0.78 | 0.58 | -2.71 | 9.32 | 2.87 | +17.67% |
| 2021 | 1.79 | -2.63 | -4.46 | 2.68 | -2.30 | 6.28 | -1.49 | 3.84 | -4.29 | 0.13 | -4.43 | 2.29 | -3.23% |
| 2022 | -10.64 | -1.64 | 5.83 | -7.32 | -4.11 | 3.15 | 4.61 | 1.26 | -2.38 | 6.20 | 5.78 | -3.39 | -4.31% |
| 2023 | 2.65 | -5.92 | -0.03 | 1.99 | -1.27 | 1.11 | -0.85 | -0.55 | -4.78 | -6.38 | 5.73 | 13.17 | +3.40% |
| 2024 | 1.22 | 1.02 | -0.28 | -6.53 | 3.45 | 5.35 | 6.03 | 1.43 | -2.69 | -1.81 | 0.20 | -7.38 | - |
| 2025 | 0.65 | - | - | - | - | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 19.36% | 18.78% | 17.56% | 20.25% | 22.80% |
| Índice de Sharpe | 0.45 | -1.07 | -0.26 | 0.07 | -0.01 |
| El mes mejor | +0.65% | +6.03% | +6.03% | +13.17% | +13.17% |
| El mes peor | -7.38% | -7.38% | -7.38% | -10.64% | -10.64% |
| Pérdida máxima | -4.23% | -14.92% | -14.92% | -20.92% | -31.53% |
| Rendimiento superior | -5.08% | - | -3.25% | - | - |
Todas las cotizaciones en CHF
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,073.4700 | +0.30% | +15.54% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,346.7500 | +6.72% | +35.12% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,570.7800 | +5.46% | +35.89% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,889.6700 | +2.78% | +28.71% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 232.5600 | +6.13% | +34.99% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 376.8300 | +5.85% | +39.64% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 345.2500 | +7.11% | +38.66% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 199.6900 | -1.87% | +12.51% | |
| Candriam Equities L Biotechnolog... | reinvestment | 149.7300 | -1.32% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,736.9600 | +2.18% | +24.48% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,098.2500 | +2.28% | +25.02% | |
| Candriam Equities L Biotech.N US... | reinvestment | 608.3000 | +1.26% | +23.09% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 198.2500 | -0.20% | +15.57% | |
| Candriam Equities L Biotech.R US... | reinvestment | 273.5000 | +2.55% | +27.77% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 207.9000 | +0.64% | +18.50% | |
| Candriam Equities L Biotechnolog... | reinvestment | 855.9900 | +1.64% | +24.56% | |
| Candriam Equities L Biotechnolog... | paying dividend | 781.6000 | +1.61% | +24.44% |
Performance
| Año hasta la fecha | +0.65% | ||
|---|---|---|---|
| 6 Meses | -9.17% | ||
| Promedio móvil | -1.87% | ||
| 3 Años | +12.51% | ||
| 5 Años | +12.84% | ||
| Desde el principio | +33.13% | ||
| Año | |||
| 2023 | +3.40% | ||
| 2022 | -4.31% | ||
| 2021 | -3.23% | ||
| 2020 | +17.67% | ||
| 2019 | +31.48% | ||
| 2018 | -13.65% | ||
| 2017 | +24.55% | ||